Blood thinner may stop organ failure in pancreatitis patients
NCT ID NCT07609771
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving the blood thinner heparin early can prevent organ failure in people hospitalized with acute pancreatitis. The inflammation from pancreatitis can cause tiny blood clots that damage organs like the lungs and kidneys. Half of the 100 participants will get standard care plus heparin, while the other half gets standard care alone. The main goal is to see if fewer people on heparin develop organ failure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Unfractionated heparin (a blood thinner)
What this could lead to
If it works, this could provide a simple, low-cost way to prevent life-threatening organ failure in acute pancreatitis, reducing deaths and hospital stays.
What could go wrong
This is a small, early-phase trial with only 100 patients. Heparin carries a risk of serious bleeding, and the benefit is unproven. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allied Hospital, Faisalabad
Faisalābad, Punjab Province, 38000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••